TITLE

Matrix Laboratories appoints S. Srinivasan as Managing Director and CEO

PUB. DATE
January 2009
SOURCE
Chemical Business;Jan2009, Vol. 23 Issue 1, p73
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article announces that S. Srinivasan was appointed as managing director and chief executive officer of Matrix Laboratories Ltd.
ACCESSION #
42542879

 

Related Articles

  • Matrix still on a buying spree.  // Chemical Market Reporter;10/3/2005, Vol. 268 Issue 11, p6 

    Reports on the success of the Hyderabad-India-based Matrix Laboratories Ltd. Expansion on the company's manufacturing and development network; Acquisition of stakes in Mchem Group and Explora Laboratories; Improvement of supply chain economics.

  • FIPB clears Mylan's FDI proposal.  // FRPT- Chemical Snapshot;8/31/2015, p21 

    The article reports that the foreign direct investment (FDI) proposal of pharmaceutical company Mylan Laboratories for a capital inflow to acquire some female health care businesses from women's health care company Famy Care Ltd. has been cleared by India's Foreign Investment Promotion Board (FIPB).

  • Matrix Laboratories to acquire Belgian drug firm.  // Chemical Business;Jul2005, Vol. 19 Issue 7, p56 

    Deals with the decision of Indian pharmaceutical Matrix Laboratories Ltd. to acquire pharmaceutical company Docpharma NV. Terms of the share purchase agreement signed by Matrix Laboratories with Docpharma; Value of the acquisition.

  • Pharmaceuticals in brief.  // Chemical Market Reporter;6/27/2005, Vol. 267 Issue 26, p21 

    Reports on developments concerning the drug industry in the United States as of July 3, 2005. Biotechnology company Codexis' signing of a deal with Matrix Laboratories to develop and commercialize an API for a "high-value pharmaceutical product; Partnership between GlaxoSmithKline Biologicals...

  • Matrix Gels Tenative O.K. for AIDS Drug.  // Chain Drug Review;10/25/2010, Vol. 32 Issue 18, p78 

    The article reports on the tentative approval received by Matrix Laboratories Ltd. from the U.S. Food and Drug Administration under the President's Emergency Plan for AIDS Relief of its Abbreviated New Drug Application for atazanavir sulfate capsules.

  • US-based Mylan to acquire Famy Care for $750-mn.  // FRPT- Chemical Snapshot;2/22/2015, p14 

    The article reports the U.S. based generic drugs maker Mylan expanding its market for women's contraceptives, and its likelihood in buying the women's health business of Mumbai (India)-based Famy Care.

  • Emerging Multi-core Realities. Meyer, Rob // Scientific Computing;Aug2006, Vol. 23 Issue 9, p25 

    The article focuses on ensuring that application software lives a long and productive life in the face of hardware changes. It is said that Interactive Supercomputing is developing middleware products to enable parallelization of Matrix Laboratory models. One way to ensure an application...

  • How Indian companies can become cornerstones in global growth plans. Malik, Rajiv // Pharmaceutical Technology;Sep2007, Vol. 31 Issue 9, p80 

    The article presents a corporate profile of Matrix Laboratories Ltd. in Hyderabad, India. It was acquired by generics company Mylan Laboratories Inc. of Pennsylvania. The acquisition was a landmark deal for the pharmaceutical sector in terms of size and the profiles of both purchaser and...

  • Power Star.  // India Today;2/11/2013, p28 

    The article offers information on Indian celebrity S. Srinivasan.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics